Timing Matters: How Irregular Meals Affect Diabetes Management

Timing Matters: How Irregular Meals Affect Diabetes Management

The study can provide useful information to interventional cardiologists performing PCI with new-generation DES in AMI patients, regarding the importance of hyperglycemia (especially prediabetes) and the relationship with worse cardiovascular outcomes after both high intensity and low-moderate-intensity statin treatment

Timing Matters: How Irregular Meals Affect Diabetes Management

New Insights into Atrial Arrhythmias Following PFO Closure

The study can provide useful information to interventional cardiologists performing PCI with new-generation DES in AMI patients, regarding the importance of hyperglycemia (especially prediabetes) and the relationship with worse cardiovascular outcomes after both high intensity and low-moderate-intensity statin treatment

Timing Matters: How Irregular Meals Affect Diabetes Management

Transforming Cardiovascular Health with Data-Driven Innovations

The study can provide useful information to interventional cardiologists performing PCI with new-generation DES in AMI patients, regarding the importance of hyperglycemia (especially prediabetes) and the relationship with worse cardiovascular outcomes after both high intensity and low-moderate-intensity statin treatment

Timing Matters: How Irregular Meals Affect Diabetes Management

Alarming Rise in Diabetes: Nearly 1 in 6 U.S. Adults Affected

The study can provide useful information to interventional cardiologists performing PCI with new-generation DES in AMI patients, regarding the importance of hyperglycemia (especially prediabetes) and the relationship with worse cardiovascular outcomes after both high intensity and low-moderate-intensity statin treatment

Timing Matters: How Irregular Meals Affect Diabetes Management

A Safer Path to Heart Health: Moderate Statin Plus Ezetimibe After PCI

The study can provide useful information to interventional cardiologists performing PCI with new-generation DES in AMI patients, regarding the importance of hyperglycemia (especially prediabetes) and the relationship with worse cardiovascular outcomes after both high intensity and low-moderate-intensity statin treatment